Aptevo Therapeutics (APVO) Short Interest Ratio & Short Volume → Automatic Income (from home) (From Awesomely, LLC) (Ad) Free APVO Stock Alerts $0.80 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Aptevo Therapeutics Short Interest DataCurrent Short Volume268,200 sharesPrevious Short Volume145,600 sharesChange Vs. Previous Month+84.20%Dollar Volume Sold Short$190,609.74Short Interest Ratio / Days to Cover0.3Last Record DateApril 30, 2024Outstanding Shares4,080,000 sharesFloat Size1,600,000 sharesShort Percent of Float16.76%Today's Trading Volume166,058 sharesAverage Trading Volume1,995,386 sharesToday's Volume Vs. Average8% Short Selling Aptevo Therapeutics ? Sign up to receive the latest short interest report for Aptevo Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAPVO Short Interest Over TimeAPVO Days to Cover Over TimeAPVO Percentage of Float Shorted Over Time Ad WealthPressHow this is some devastating newsCheck out this report real quick… It’s full proof that most people barely have enough money to cover the monthly expenditures… Let alone save for retirement or plan the next vacation. At the risk of sounding political… If you’re waiting for the Fed, or the government or some financial advisor to come to change things for the better… You might be waiting for a long long time. But what if…? What if there was a way to completely turn the tables?But I can promise that you’ll see all the details for yourself here. Aptevo Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024268,200 shares $190,609.74 +84.2%16.8%0.3 $0.71 4/15/2024145,600 shares $114,004.80 +324.5%9.1%0.6 $0.78 3/31/202434,300 shares $160,867.00 +18.7%5.1%0.3 $4.69 3/15/202428,900 shares $156,638.00 +725.7%5.5%0.3 $5.42 2/29/20243,500 shares $26,180.00 -82.1%N/A0 $7.48 2/15/202419,600 shares $3,077.20 +17.4%N/A0.1 $0.16 Get the Latest News and Ratings for APVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202416,700 shares $2,715.42 -78.8%N/A0 $0.16 1/15/202478,900 shares $12,545.10 -61.3%N/A0.2 $0.16 12/31/2023203,900 shares $36,905.90 +253.4%N/A0.3 $0.18 12/15/202357,700 shares $9,924.40 -46.0%N/A0.1 $0.17 11/30/2023106,800 shares $19,971.60 +297.0%N/A0.2 $0.19 11/15/202326,900 shares $4,976.50 -74.2%N/A0.1 $0.19 10/31/2023104,300 shares $29,485.61 -19.3%N/A0.2 $0.28 10/15/2023129,200 shares $41,344.00 +7.4%N/A0.3 $0.32 9/30/2023120,300 shares $39,699.00 +161.5%N/A0.4 $0.33 9/15/202346,000 shares $18,446.00 -46.6%N/A0.1 $0.40 8/31/202386,200 shares $37,928.00 +176.3%N/A0.3 $0.44 8/15/202331,200 shares $11,544.00 -97.8%N/A0.1 $0.37 7/31/20231,390,000 shares $1.45 million +3,837.7%N/A5.6 $1.04 7/15/202335,300 shares $52,950.00 +13.1%N/A0.2 $1.50 6/30/202331,200 shares $45,552.00 +51.5%N/A0.6 $1.46 6/15/202320,600 shares $32,960.00 -59.7%N/A0.4 $1.60 5/31/202351,100 shares $79,716.00 -28.0%N/A1 $1.56 5/15/202371,000 shares $117,150.00 -47.6%N/A1.3 $1.65 4/30/2023135,500 shares $260,160.00 +47.8%N/A2.4 $1.92 4/15/202391,700 shares $174,230.00 -35.1%N/A1.6 $1.90 3/31/2023141,200 shares $287,342.00 +34.2%N/A2 $2.04 3/15/2023105,200 shares $190,412.00 -30.1%N/A1.2 $1.81 2/28/2023150,400 shares $318,848.00 +118.6%N/A0.2 $2.12 2/15/202368,800 shares $141,040.00 -49.1%N/A0.1 $2.05 1/31/2023135,100 shares $310,730.00 -27.3%N/A0.2 $2.30 1/15/2023185,800 shares $418,050.00 -32.3%N/A0.2 $2.25 12/30/2022274,500 shares $636,840.00 -38.8%N/A0.4 $2.32 12/15/2022448,700 shares $1.01 million +764.6%N/A0.6 $2.25 11/30/202251,900 shares $161,928.00 -2.8%N/A1.5 $3.12 11/15/202253,400 shares $178,890.00 -12.3%N/A1.5 $3.35 10/31/202260,900 shares $183,918.00 +6.8%N/A1.3 $3.02 10/15/202257,000 shares $161,310.00 +8.6%N/A0.9 $2.83 9/30/202252,500 shares $159,600.00 +23.8%N/A0.9 $3.04 9/15/202242,400 shares $158,576.00 +3.9%N/A0.7 $3.74Free report reveals “two-baggers” for 2024 (Ad)We’ve put together something special for our subscribers — a free report on 5 stocks we believe could double in 2024. It’s straightforward, easy to understand, and most importantly, actionable.Download your free report today! APVO Short Interest - Frequently Asked Questions What is Aptevo Therapeutics' current short interest? Short interest is the volume of Aptevo Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 268,200 shares of APVO short. 16.76% of Aptevo Therapeutics' shares are currently sold short. Learn More on Aptevo Therapeutics' current short interest. Which institutional investors are shorting Aptevo Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aptevo Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Aptevo Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.76% of Aptevo Therapeutics' floating shares are currently sold short. Is Aptevo Therapeutics' short interest increasing or decreasing? Aptevo Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 268,200 shares, an increase of 84.2% from the previous total of 145,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aptevo Therapeutics' float size? Aptevo Therapeutics currently has issued a total of 4,080,000 shares. Some of Aptevo Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aptevo Therapeutics currently has a public float of 1,600,000 shares. How does Aptevo Therapeutics' short interest compare to its competitors? 16.76% of Aptevo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Aptevo Therapeutics: China SXT Pharmaceuticals, Inc. (2.63%), Aditxt, Inc. (8.48%), Comera Life Sciences Holdings, Inc. (2.38%), SciSparc Ltd. (4.18%), Sunshine Biopharma, Inc. (29.84%), Neptune Wellness Solutions Inc (0.54%), Evelo Biosciences, Inc. (2.11%), Lucy Scientific Discovery Inc. (3.32%), GRI Bio, Inc. (0.46%), NeuBase Therapeutics, Inc. (0.51%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Aptevo Therapeutics stock? Short selling APVO is an investing strategy that aims to generate trading profit from Aptevo Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aptevo Therapeutics? A short squeeze for Aptevo Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APVO, which in turn drives the price of the stock up even further. How often is Aptevo Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APVO, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: SXTC Short Interest Data ADTX Short Interest Data CMRA Short Interest Data SPRC Short Interest Data SBFM Short Interest Data NEPT Short Interest Data EVLO Short Interest Data LSDI Short Interest Data GRI Short Interest Data NBSE Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APVO) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits